BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32023530)

  • 1. Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database.
    Guru Murthy GS; Szabo A; Michaelis L; Carlson KS; Runaas L; Abedin S; Atallah E
    J Natl Compr Canc Netw; 2020 Feb; 18(2):169-175. PubMed ID: 32023530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and survival of therapy related myeloid neoplasm in United States.
    Guru Murthy GS; Hamadani M; Dhakal B; Hari P; Atallah E
    Leuk Res; 2018 Aug; 71():95-99. PubMed ID: 30048839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-Level Outcomes of Pediatric Acute Promyelocytic Leukemia in the United States.
    Venkitachalam R; Szabo A; Guru Murthy GS
    J Pediatr; 2020 Aug; 223():114-119.e5. PubMed ID: 32482395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.
    Braun T; Cereja S; Chevret S; Raffoux E; Beaumont M; Detourmignies L; Pigneux A; Thomas X; Bordessoule D; Guerci A; Lamy T; Recher C; Poiré X; Tournilhac O; Spertini O; Chomienne C; Degos L; Dombret H; Adès L; Fenaux P;
    Cancer; 2015 Jul; 121(14):2393-9. PubMed ID: 25845577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience.
    Pulsoni A; Pagano L; Lo Coco F; Avvisati G; Mele L; Di Bona E; Invernizzi R; Leoni F; Marmont F; Mele A; Melillo L; Nosari AM; Pogliani EM; Vignetti M; Visani G; Zagonel V; Leone G; Mandelli F
    Blood; 2002 Sep; 100(6):1972-6. PubMed ID: 12200354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of insurance status on the survival of younger patients diagnosed with acute promyelocytic leukemia in the United States.
    Jamy OH; Godby R; Dhir A; Costa LJ; Xavier AC
    Cancer; 2021 Aug; 127(16):2966-2973. PubMed ID: 33891351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
    Nasir SS; Giri S; Nunnery S; Martin MG
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcome of childhood acute promyelocitic leukemia (APL) in Saudi Arabia: a multicenter SAPHOS leukemia group study.
    Jastaniah W; Alsultan A; Al Daama S; Ballourah W; Bayoumy M; Al-Anzi F; Al Shareef O; Abrar MB; Al Sudairy R; Al Ghemlas I
    Hematology; 2018 Jul; 23(6):316-323. PubMed ID: 29212418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
    Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
    Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing the room for improvement in management of acute promyelocytic leukemia.
    Nørgaard JM; Friis LS; Kristensen JS; Severinsen MT; Mølle I; Marcher CW; Møller P; Schoellkopf C; Nielsen OJ; Preiss BS; Andersen MK; Kjeldsen E; Medeiros BC; Østgård LSG;
    Eur J Haematol; 2019 Jun; 102(6):479-485. PubMed ID: 30887583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiological trend of acute promyelocytic leukemia over past four decades: a population-based analysis.
    Chen Z; Mai W; Li Z; Zhang H; Zheng Y; Hong S; Yang W; Xiao W; Chen Z; Wang S
    Leuk Lymphoma; 2019 Dec; 60(14):3470-3481. PubMed ID: 31305195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes.
    Swaika A; Frank RD; Yang D; Finn LE; Jiang L; Advani P; Chanan-Khan AA; Ailawadhi S; Foran JM
    Cancer Med; 2018 Feb; 7(2):499-507. PubMed ID: 29282894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Survival Outcomes Between De Novo and Secondary Acute Promyelocytic Leukemia: An Updated Population-based study.
    Tao Y; Yu YQ; Liu YY; Jia M; Gao L
    Clin Lymphoma Myeloma Leuk; 2022 Jan; 22(1):e7-e14. PubMed ID: 34462244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of de novo acute myeloid leukemia in the United States: a report from the Patterns of Care program.
    Doria-Rose VP; Harlan LC; Stevens J; Little RF
    Leuk Lymphoma; 2014 Nov; 55(11):2549-55. PubMed ID: 24467221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and outcomes of cutaneous angiosarcoma: A SEER population-based study.
    Conic RRZ; Damiani G; Frigerio A; Tsai S; Bragazzi NL; Chu TW; Mesinkovska NA; Koyfman SA; Joshi NP; Budd GT; Vidimos A; Gastman BR
    J Am Acad Dermatol; 2020 Sep; 83(3):809-816. PubMed ID: 31310841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of Early Death in Acute Promyelocytic Leukemia: A Population-Based Analysis.
    Li G; Wu J; Li R; Pan Y; Ma W; Xu J; Nan M; Hou L
    Clin Lymphoma Myeloma Leuk; 2023 Feb; 23(2):e78-e84. PubMed ID: 36567214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
    Guru Murthy GS; Szabo A; Hamadani M; Fenske TS; Shah NN
    Oncologist; 2019 Nov; 24(11):1488-1495. PubMed ID: 31467178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
    Chen W; Huang Y; Lewis GD; Szeja SS; Hatch SS; Farach A; Miltenburg D; Butler EB; Chang JC; Teh BS
    Clin Breast Cancer; 2018 Feb; 18(1):e97-e105. PubMed ID: 28888581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
    Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
    Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary acute promyelocytic leukemia. Characteristics and prognosis of 14 patients from a single institution.
    Pollicardo N; O'Brien S; Estey EH; al-Bitar M; Pierce S; Keating M; Kantarjian HM
    Leukemia; 1996 Jan; 10(1):27-31. PubMed ID: 8558933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.